COUNTERPOINT: Routine Use of Autologous Stem Cell Transplantation in Multiple Myeloma
August 15, 2016
Myeloma is clearly not one disease but several. In terms of treatment choices, it is increasingly evident that one size of treatment does not fit all. Moreover, as therapy is tailored to each individual patient, with the ability to mobilize and collect stem cells and retain them after successful induction/remission therapy, younger patients have choices.